Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

[1]  Jonathan W. Kanen,et al.  Angiotensin blockade enhances motivational reward learning via enhancing striatal prediction error signaling and frontostriatal communication , 2023, bioRxiv.

[2]  Ming Lu,et al.  Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway , 2022, Journal of neuroinflammation.

[3]  M. Ueda,et al.  Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias , 2022, Nature communications.

[4]  Hui Li,et al.  Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor. , 2021, Journal of Alzheimer's disease : JAD.

[5]  T. Ishrat,et al.  Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain. , 2021, Journal of Alzheimer's disease : JAD.

[6]  Hui Li,et al.  Knockdown of astrocytic Grin2a aggravates β‐amyloid‐induced memory and cognitive deficits through regulating nerve growth factor , 2021, Aging cell.

[7]  T. Horvath,et al.  Therapy for Alzheimer’s disease: Missing targets and functional markers? , 2021, Ageing Research Reviews.

[8]  Mengping Wei,et al.  Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons , 2020, Autophagy.

[9]  L. Buée,et al.  Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains , 2020, Acta Neuropathologica.

[10]  V. Kulkarni,et al.  An in-silico approach: identification of PPAR-γ agonists from seaweeds for the management of Alzheimer’s Disease , 2020, Journal of biomolecular structure & dynamics.

[11]  A. Araque,et al.  G-Protein-Coupled Receptors in Astrocyte–Neuron Communication , 2020, Neuroscience.

[12]  Ping-yuan Wang,et al.  ATM‐CHK2‐Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress , 2020, The EMBO journal.

[13]  S. Liggett,et al.  β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates , 2020, Proceedings of the National Academy of Sciences.

[14]  Sheng-feng Ji,et al.  Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer’s disease via activation of α7nAChR , 2020, Neurobiology of Learning and Memory.

[15]  C. Tzourio,et al.  Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies , 2019, The Lancet Neurology.

[16]  M. Sabbagh,et al.  The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis , 2019, Alzheimer's & Dementia.

[17]  R. Touyz,et al.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure , 2019, Pharmacological Reviews.

[18]  R. Swerdlow,et al.  Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer′s disease , 2019, Science Translational Medicine.

[19]  Ming Lu,et al.  The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression , 2019, Cell Death & Disease.

[20]  P. Albert,et al.  Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. , 2019, Pharmacology & therapeutics.

[21]  S. Beer-Hammer,et al.  Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats , 2019, Neurotherapeutics.

[22]  J. Kotlinska,et al.  Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological consideration , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

[23]  J. Born,et al.  The hippocampus is crucial for forming non-hippocampal long-term memory during sleep , 2018, Nature.

[24]  M. Reed,et al.  Neuroprotective effects of INT-777 against Aβ1–42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice , 2018, Brain, Behavior, and Immunity.

[25]  M. Clark,et al.  Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[26]  R. Shukla,et al.  Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/β-Catenin Signaling in Hypertension , 2017, Molecular Neurobiology.

[27]  Zijian Li,et al.  New Insights into Modes of GPCR Activation. , 2018, Trends in pharmacological sciences.

[28]  A. Ergul,et al.  Within the Brain: The Renin Angiotensin System , 2018, International journal of molecular sciences.

[29]  Hailan Hu,et al.  Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression , 2018, Nature.

[30]  Yi Fu,et al.  Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury , 2018, Nature Communications.

[31]  D. Kang,et al.  Spirulina maxima Extract Ameliorates Learning and Memory Impairments via Inhibiting GSK-3β Phosphorylation Induced by Intracerebroventricular Injection of Amyloid-β 1–42 in Mice , 2017, International journal of molecular sciences.

[32]  J. Lanciego,et al.  Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans , 2017, Molecular Neurobiology.

[33]  P. Kehoe,et al.  Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology. , 2017, Journal of Alzheimer's disease : JAD.

[34]  Sung Hyun Kim,et al.  Synapses in neurodegenerative diseases , 2017, BMB reports.

[35]  M. Rudd,et al.  Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.

[36]  B. Russell,et al.  Long-Term Biased &bgr;-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy , 2017, Circulation.

[37]  A. Brass,et al.  Frizzled are colonic epithelial receptors for Clostridium difficile toxin B , 2016, Nature.

[38]  M. Sastre,et al.  Mechanisms of Aβ Clearance and Degradation by Glial Cells , 2016, Front. Aging Neurosci..

[39]  Uwe Maskos,et al.  Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment , 2015, Neuropharmacology.

[40]  M. Kim,et al.  Melatonin ameliorates amyloid beta‐induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus , 2015, Journal of pineal research.

[41]  J. Violin,et al.  Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model. , 2015, Cardiovascular research.

[42]  K. Zou,et al.  Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology , 2015, Scientific Reports.

[43]  N. Dantuma,et al.  The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution , 2014, Front. Mol. Neurosci..

[44]  Sebastian Munck,et al.  β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease , 2013, Nature Medicine.

[45]  A. Ballabio,et al.  Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder , 2012, Proceedings of the National Academy of Sciences.

[46]  Chien-Yu Huang,et al.  Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders , 2012, Molecular Neurobiology.

[47]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[48]  Yanjiang Wang,et al.  The p75NTR extracellular domain , 2011, Prion.

[49]  T. Owens,et al.  Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system , 2011, Brain, Behavior, and Immunity.

[50]  Lisa Nguyen,et al.  Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance , 2010, Journal of Pharmacology and Experimental Therapeutics.

[51]  K. Rakesh,et al.  β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress , 2010, Science Signaling.

[52]  M. Mogi,et al.  Cognitive Deficit in Amyloid-&bgr;–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-&ggr; Activation , 2009, Hypertension.

[53]  M. Miyatake,et al.  Inhibition of EGF‐induced ERK/MAP kinase‐mediated astrocyte proliferation by μ opioids: integration of G protein and β‐arrestin 2‐dependent pathways , 2009, Journal of neurochemistry.

[54]  J. Parga,et al.  Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS , 2008, Neurobiology of Disease.

[55]  T. Noda,et al.  Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3 , 2007, Autophagy.

[56]  E. Sigurdsson,et al.  Plaque-Associated Overexpression of Insulin-Degrading Enzyme in the Cerebral Cortex of Aged Transgenic Tg2576 Mice With Alzheimer Pathology , 2006, Journal of neuropathology and experimental neurology.

[57]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[58]  R. Schliebs,et al.  Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques , 2003, Neuroscience Letters.

[59]  J. Wegiel,et al.  Spatial relationships between astrocytes and classical plaque components , 1991, Neurobiology of Aging.